Acute abdominal pain, a set of symptoms developing in patients having pathology of the gastrointestinal tract, abdominal cavity and retroperitoneal space, is known as one of the leading causes for surgical hospitalization both in Ukraine and abroad. The aim of this study was to evaluate the effects of a combination drug "Neospastil", which belongs to the group of antispasmodics in combination with analgesics, on the severity of symptoms of abdominal spastic pain in order to improve the treatment of patients. This clinical study included 90 patients with a clinical picture of abdominal pain syndrome, who were hospitalized to the surgical departments. The patients were divided into 3 groups, 30 patients in each. We used various options for antispasmodic and analgesic therapy and compared their effectiveness in terms of the time of the onset of the analgesic effect, the time period of relieving abdominal spasm, and the duration of the periods between repeated spastic pain attacks. The results of our study demonstrated the use of the combined drug "Neospastil" in the management of acute abdominal pain syndrome even in the first day enabled to reduce the severity of the pain syndrome by 38% compared with the drotaverine therapy and by 19% compared with analogues of the combined drugs. The period of the occurrence of subsequent spastic pains was prolonged with the study drug by 2.2 ± 0.5 hours compared with drotaverine and by 1.1 ± 0.1 hours compared with spasmalgon. When using “Neospastil”, a decrease in the duration of an attack of abdominal spasm was noted by 29% compared with drotaverine and by 22% compared with spasmalgon. Summarizing the obtained data, we can recommend the use of “Neospastil” for the primary therapy of abdominal spastic pain in surgical patients that will lead to an improvement in the clinical treatment outcomes.

No abstract

No abstract

Based on the widespread incidence of acute pyelonephritis, which is one of the most common inflammatory diseases of the urinary system, it is important to conduct searching for improved treatment methods, which would ensure higher effectiveness of clinical regression of the process and minimize the extent of manipulations and pharmacotherapy. Pyelovesical bypass is one of these methods. The aim of this study is to investigate the efficacy of pyelovesical drainage of the urinary tract in the course of acute pyelonephritis in comparison with conservative methods of treatment in order to identify its advantages and disadvantages. To assess the effect of urinary tract drainage, we analyzed the clinical findings of patients with acute obstructive pyelonephritis, who underwent pyelovesical stenting and compared them with standard conservative treatment methods. According to the data obtained, we can conclude that pyelovesical stenting procedure in cases of acute obstructive pyelonephritis provides a statistically significant acceleration of the regression of clinical manifestations of kidney inflammation, such as hyperthermic reaction, pain syndrome, inflammatory changes in the blood and urine, parameters of ultrasonic dynamics. Thus, in the presence of clinical indications, appropriate technical conditions, devices and qualified surgeons to perform stenting, we can recommend this method as an effective means of integrated treatment for this renal pathology.

Узагальнені результати лікування 26 хворих, у яких після оперативного втручання виникло нагноєння лапаротомної рани. Комплексне лікування з використанням метаболітотропної терапії сприяло більш швидкому загоєнню ран та ерадикації патогенної мікрофлори.